适应式探戈与适应式探戈的16个月的合规性和满意度. 对于患有帕金森病的人来说,有监督的步行
Haneul Kim1,2, Forouzan Rafie3, Amir H Nekouei4
1Rollins School of Public Health, Emory University, Atlanta, GA, USA.
NPJ Parkinson's disease
|December 26, 2025
概括
帕金森病患患有动力障碍的患者表现出较低的炼计划遵守性. 认知功能对满意度产生了积极的影响,突出了个性化炼干预措施的必要性,以改善坚持和结果.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 运动科学 运动科学
背景情况:
- 帕金森病 (PD) 管理通常包括运动,但坚持和满意可能是具有挑战性的.
- 了解影响运动遵守和满意度的因素对于优化治疗策略至关重要.
研究的目的:
- 探索帕金森病特征与炼计划遵守和满意度之间的关联.
- 确定特定的PD指标,与适应的探戈和监督步行计划的出席率和满意度相关联.
主要方法:
- 一项临床试验的二次分析,该试验涉及36名PD参与者进行适应的探戈 (AT) 或监督步行 (WALK) 16个月.
- 收集的PD指标包括动力障碍,OFF时间,步态结 (FOG),疾病持续时间,Hoehn-Yahr阶段以及运动/认知功能.
- 线性回归模型评估了PD特征,出席率和满意度之间的关系.
主要成果:
- 出席率有显著差异;整体满意度是有利的 (4.0/5.0).
- 动力障碍指标 (频率和持续时间) 与运动遵从性负相关 (p<0.06).
- 认知功能 (MoCA评分) 是最强的满意度预测指标 (p=0.050),其次是MDS-UPDRS评分 (p=0.093). 合规性积极预测的满意度 (p=0.063). FOG没有显著影响出席率或满意度.
结论:
- 功能障碍症可能会阻碍帕金森病的运动遵从性.
- 增强的认知功能与在炼计划中获得更大的满意度有关.
- 对PD患者的运动计划应量身定制,考虑运动波动和认知状态,以提高坚持和满意度.
相关概念视频
01:24Parkinson's Disease: Treatment
933
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
933
01:15Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K